The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
PHREESIA INC | Com | 71944F106 | 446 | 13,863 | SH | DFND | 446 | 0 | 0 | ||
PTC THERAPEUTICS INC | Com | 69366J200 | 382 | 8,180 | SH | DFND | 382 | 0 | 0 | ||
SANOFI-AVENTIS | Com | 80105N105 | 4,288 | 85,476 | SH | DFND | 4,228 | 0 | 0 |